Maravai LifeSciences Holdings Inc’s recently made public that its Director DeFord John A acquired Company’s shares for reported $0.1 million on Nov 12 ’24. In the deal valued at $5.75 per share,17,500 shares were bought. As a result of this transaction, DeFord John A now holds 70,046 shares worth roughly $0.35 million.
Then, HULL CARL bought 175,000 shares, generating $987,000 in total proceeds. Upon buying the shares at $5.64, the insider now owns 175,000 shares.
Before that, GTCR INVESTMENT XI LLC sold 9,940,974 shares. Maravai LifeSciences Holdings Inc shares valued at $97,570,660 were divested by the Director at a price of $9.81 per share. As a result of the transaction, GTCR INVESTMENT XI LLC now holds 20,150,005 shares, worth roughly $99.34 million.
Guggenheim initiated its Maravai LifeSciences Holdings Inc [MRVI] rating to a Neutral in a research note published recently. A number of analysts have revised their coverage, including Goldman’s analysts, who decreased its forecast for the stock in early December from “a Neutral” to “a Sell”. Wolfe Research began covering MRVI with “Peer perform” recommendation on November 14, 2024. William Blair revised its rating on November 08, 2024. It rated MRVI as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of MRVI
On Monday, Maravai LifeSciences Holdings Inc [NASDAQ:MRVI] saw its stock jump 1.75% to $4.93. Over the last five days, the stock has lost -13.12%. Maravai LifeSciences Holdings Inc shares have fallen nearly -9.45% since the year began. Nevertheless, the stocks have fallen -27.43% over the past one year. While a 52-week high of $11.56 was reached on 01/08/25, a 52-week low of $4.28 was recorded on 01/10/25. SMA at 50 days reached $5.74, while 200 days put it at $7.83.
Levels Of Support And Resistance For MRVI Stock
The 24-hour chart illustrates a support level at 4.80, which if violated will result in even more drops to 4.66. On the upside, there is a resistance level at 5.18. A further resistance level may holdings at 5.42. The Relative Strength Index (RSI) on the 14-day chart is 39.44, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 80.70%. Stochastics %K at 42.04% indicates the stock is a holding.
How much short interest is there in Maravai LifeSciences Holdings Inc?
A steep rise in short interest was recorded in Maravai LifeSciences Holdings Inc stocks on 2024-12-31, growing by 0.6 million shares to a total of 8.51 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 7.9 million shares. There was a rise of 7.1%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 28, 2024 when Wells Fargo began covering the stock and recommended ‘”an Overweight”‘ rating along with a $10 price target.
